EMT (Emerging Medical Technologies)® in the Spotlight - Online Meetings

Members & Registered Participants
Login Here:
Username:
Password:
Forgot Password? | Forgot Username?

Event Information:
- Frequently Asked Questions
-



EVENT HOST:


EVENT SPONSORS:




LSI Q4 2010 Emerging Medical Technologies (EMT) Spotlight



Location & Time: Online & Now
Attendee Registration: $199

     

AGENDA

General Track

Spotlighting 20-30 private emerging companies
Alpha Cancer Technologies - Highly effective non-toxic cancer therapy based on the use of recombinant human alpha-fetoprotein conjugated with cytotoxic drug
 
bioZhena - In vivo tissue bioprobe to help women get pregnant, automatically detecting pregnancy and any early pregnancy loss, with additional uses central to womens health and lifestyle
 
Cytonics - Molecular diagnostics and therapeutics for back-related and joint-related pain
 
EndoEvolution - Minimally invasive surgical suturing devices, using standard type curved needles and all standard sutures, for conventional and single-port laparoscopy, urogynecology, cardiac surgery, and endoscopic interventional therapies, including NOTES
 
EndoSphere - The SatiSphere System is a non-invasive obesity device that safely and effectively uses the body's natural physiology to treat obesity by regulating satiation mechanisms, slowing digestion, and discouraging excessive eating
 
Epinex Diagnostics - A rapid, monthly test that uses glycated albumin to monitor gestational and type 2 diabetes more effectively
 
Health Research Sciences (aka HRS) - Inexpensive device to provide easy and efficient screening methods for early detection of age-related macular degeneration, diabetic maculopathy, and other types of retinal disease in the human eye
 
Implandata Ophthalmic Products (aka IOP) - Transforming glaucoma care via remote 24-hour measurement of intraocular pressure
 
Molecular Detection (aka MDI) - Molecular diagnostic assays for infectious diseases, with an initial focus on hospital-acquired infections
 
Neosthetic - Leak-proof, rupture-proof breast implant technology, with the potential to replace all existing saline and gel implants
 
NivaSonix - Next-generation ultrasound technology for non-invasive fat and wrinkle reduction, with multiple clinical applications in one device and no surgery or anesthesia
 
NsGene - Biological therapeutics for the treatment of neurological disorders including: Alzheimer's disease, epilepsy, Huntington's disease, Parkinson's disease, and neuropathic pain
 
Pepex Biomedical - Electrochemical biosensors for the in-hospital diagnostics, home health care, and consumer diabetes markets
 
Pico-Tesla Magnetic Therapies - Non-invasive neuromodulation technology platform to therapeutically address several major areas of disease; the Company's lead indication is Parkinson's Disease (PD)
 
Power Paper - The first-and-only, fully self-contained, low-cost, and market-proven disposable iontophoretic patch - topical drug delivery platform for enhanced penetration and efficacy
 
Profound Technologies (aka Pro-Tech Med) - New medical grade preservative that is non-toxic and capable of preserving urine, blood, plasma, and serum at room temperature; designed and used by the space program
 
ScienceTomorrow - Implant fault detection and monitoring technology
 
Teneo Medical Development - IVC filter utilizing unique anchoring technology that allows for optimal placement during implantation, superior migration resistance in vivo, and easy retrieval after the threat of PE has been eliminated
 
Valor Medical - 1-Next-generation liquid embolic for treating cerebral aneurysms and arteriovenous malformations (AVMs); 2-Two wound management products that will be out-licensed
 
VectraCor - Technology that can detect in real time an acute myocardial infarction and derive a 12-22 lead ECG with only 3 leads or 5 electrodes
 
Venous Health Systems - A portable pneumatic compression system for the treatment of venous and arterial insufficiency, to be used in the hospital, secondary care facility, and home
 
Vital Access (fka IVIT) - Percutaneous anastomosis device to improve long-term vascular access for dialysis and cancer patients
 

For each company a 2-page executive summary and 10-minute CEO presentation (audio and slides) will be provided along with LSI’s summary of their development status, fundraising/partnering needs, etc.  Information covered will include market, technology, business strategy, management team, financial status, sales forecasts, IP position, and much more. 

Virtual networking/partnering tool will be available to reach out to companies and request private meetings.